Oncology Drugs Market Research Report, Growth & Forecast

This study covers the world outlook for chemotherapy and antibody combination antibody therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or p...

This study covers the world outlook for colorectal cancer chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu...

This study covers the world outlook for colorectal cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings...

This study covers the world outlook for cutaneous melanoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earning...

This study covers the world outlook for disease-specific chronic myelogenous leukemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or p...

This study covers the world outlook for doxorubicin across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...

This study covers the world outlook for endocrine pancreatic cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earni...

This study covers the world outlook for endometrial cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings...

This study covers the world outlook for glioblastoma multiforme drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings...

This study covers the world outlook for gynaecological cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...

This study covers the world outlook for HER-2 positive breast cancer chemotherapy across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust...

This study covers the world outlook for Hodgkins lymphoma drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...

This study covers the world outlook for hormone-drug breast cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry...

This study covers the world outlook for hormone therapy for prostate cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential...

This study covers the world outlook for immune checkpoint inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...

This study covers the world outlook for immuno-oncology immune checkpoint inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential ind...

This study covers the world outlook for immunotherapy cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....

This study covers the world outlook for monoclonal antibodies market in breast cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential i...

This study covers the world outlook for multiple myeloma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...

This study covers the world outlook for multiple myeloma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...

This study covers the world outlook for non-Hodgkin lymphoma chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential i...

This study covers the world outlook for non-Hodgkin lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earning...

This study covers the world outlook for non-Hodgkin's lymphoma and chronic lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or pot...

This study covers the world outlook for NSCLC therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...

This study covers the world outlook for oncology therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...

This study covers the world outlook for ovarian cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...

This study covers the world outlook for pediatric neuroblastoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earn...

This study covers the world outlook for premetrexed and combinations for malignant mesothelioma across more than 190 countries. For each year reported, estimates are given for the latent demand, or po...

The Global Ovarian Cancer Drugs Market will grow from USD 4.32 Billion in 2025 to USD 6.36 Billion by 2031 at a 6.66% CAGR. Ovarian cancer drugs encompass a diverse range of pharmacological interventi...

HNY Research projects that the Pertuzumab market size will grow from 283.56 Million USD in 2025 to 417.13 Million USD by 2031, at an estimated CAGR of 6.64%. The base year considered for the study is...

HNY Research projects that the Recombinant Human Endostatin market size will grow from 162.61 Million USD in 2025 to 277.01 Million USD by 2031, at an estimated CAGR of 9.28%. The base year considered...

According to our (Global Info Research) latest study, the global Anticancer Drugs market size was valued at US$ 233550 million in 2025 and is forecast to a readjusted size of US$ 480980 million by 203...

HNY Research projects that the Follicular Lymphoma Treatment market size will grow from 1871.28 Million USD in 2025 to 2373.83 Million USD by 2031, at an estimated CAGR of 4.04%. The base year conside...

HNY Research projects that the Oncology Injection Drug market size will grow from 186.29 Million USD in 2025 to 274.86 Million USD by 2031, at an estimated CAGR of 6.7%. The base year considered for t...

HNY Research projects that the Recurrent Glioblastoma Multiforme Treatment market size will grow from 529.86 Million USD in 2025 to 787.64 Million USD by 2031, at an estimated CAGR of 6.83%. The base...

The global Chemotherapy Infusion Pumps market size is expected to reach $ 391 million by 2032, rising at a market growth of 6.6% CAGR during the forecast period (2026-2032). Chemotherapy pumps are one...

The global Intravesical Bacillus Calmette market size is expected to reach $ 614 million by 2032, rising at a market growth of 8.0% CAGR during the forecast period (2026-2032). Intravesical Bacillus C...

The global Medical Asparaginase market size is expected to reach $ 440 million by 2032, rising at a market growth of 1.5% CAGR during the forecast period (2026-2032). Asparaginase is an enzyme, as a m...

The global Peptide Cancer Vaccine market size is expected to reach $ million by 2032, rising at a market growth of 19.3% CAGR during the forecast period (2026-2032). Peptide cancer vaccines are innova...

The global Topotecan Hydrochloride market size is expected to reach $ million by 2032, rising at a market growth of %CAGR during the forecast period (2026-2032). Topotecan Hydrochloride is the hydroch...

The global Tyrosine Kinase JAK Inhibitors market size is expected to reach $ 113500 million by 2032, rising at a market growth of 2.1% CAGR during the forecast period (2026-2032). Tyrosine kinase JAK...

The global Anticancer Drugs market size is expected to reach $ 480980 million by 2032, rising at a market growth of 11.0% CAGR during the forecast period (2026-2032). Anticancer drugs are medications...

The global Paclitaxel market size is expected to reach $ 259 million by 2032, rising at a market growth of 8.0% CAGR during the forecast period (2026-2032). Paclitaxel is a mitotic inhibitor used in C...

The Liposarcoma Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled...

The brain tumor drugs market, growing at a 7.36% CAGR, is anticipated to reach USD 4.276 billion in 2031 from USD 2.792 billion in 2025. The brain tumor drugs market is a critical and high-stakes segm...

Findings & Highlights: Global Claudin18.2 Targeted Therapy Market Opportunity: > US$ 800 Million By 2030Number Of Approved Claudin18.2 Targeted Therapy: 1Approved Claudin18.2 Targeted Therapy Dosage,...

Findings & Highlights: First MYC Targeting Therapy Approval Expected By 2030Global MYC Targeting Therapies Market Opportunity OutlookComprehensive Insight On MYC Targeting Therapies In Clinical Trial...

Findings & Highlights: Global & Regional Market Trends InsightNumber Of Approved EZH2 Targeted Therapies: 2 TherapiesConditional Approval To EZH2 Therapy: 1 TherapyApproved Therapy Dosage, Price & Sa...

: The global market for oncology biosimilars is estimated to grow from $9.6 billion in 2025 and projected to reach $17.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.6%...

The global cancer immunotherapy market size is likely to reach USD 126.9 billion by 2026, according to a new ... number of approvals for new immunotherapeutic drugs is driving the global market. Cancer immunotherapy has emerged as a new avenue for revenue generation for pharmaceutical ...